Rashmi Kothary

Dr. Kothary is a Senior Scientist at the Ottawa Hospital Research Institute (OHRI) and has served as OHRI’s Deputy Scientific Director since 2012. He received a PhD in Biochemistry from the University of British Columbia and pursued postdoctoral research in the laboratories of Dr. Janet Rossant at the Mount Sinai Hospital Research Institute in Toronto and Dr. Azim Surani in Cambridge, U.K. It was during these formative years that Dr. Kothary developed his interests in pre-clinical models to study disease pathology. He has held the University Health Research Chair in Neuromuscular Disorders and is a Professor at the University of Ottawa. His current research focuses on investigating factors important for oligodendrocyte mediated myelination and remyelination of the CNS (in the context of Multiple Sclerosis) and understanding Spinal Muscular Atrophy pathogenesis to identify novel therapeutics for this devastating children’s disease. He currently sits on the SMA Beyond advisory board and on the scientific advisory board for RHU SMART (France), MDA and Cure SMA, and is a reviewer for the CIHR, NIH, Shriners Hospitals, MS Soc, and MDC.